Your browser doesn't support javascript.
loading
Suppressing LncRNA HOXA-AS3 by CRISPR-dCas9 inhibits pancreatic cancer development.
Zhang, Xiaoli; Zhu, Hongbo; Qu, Xiaoguang; Yu, Ziying; Zhang, Jing.
Afiliación
  • Zhang X; The First Affiliated Hospital, Department of Pathology, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China.
  • Zhu H; The First Affiliated Hospital, Department of Pathology, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China.
  • Qu X; The First Affiliated Hospital, Department of Pathology, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China.
  • Yu Z; The First Affiliated Hospital, Department of Pathology, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China.
  • Zhang J; The First Affiliated Hospital, Department of Pathology, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China.
J Cancer ; 12(21): 6439-6444, 2021.
Article en En | MEDLINE | ID: mdl-34659534
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Cancer Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Australia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Cancer Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Australia